ASRC Press Releases

NAD Finds Olly Public Benefit Co. Can Support Challenged Claims for ‘Kids Mighty Immunity Supplement’

NAD has determined that Olly Public Benefit Company can support challenged claims for the company’s “Kids Mighty Immunity Supplement,” including the claim “formulated to help support little immune systems in the biggest way to help keep kids healthy and happy year-round.”

Read More

NAD Refers Advertising for Prestige Brands’ Nix Ultra Lice Removal System to FTC After Advertiser Declines to Discontinue ‘Kill’ Claims

NAD has referred advertising claims made by Prestige Brands for its Nix Ultra Lice Removal System to the FTC for further review after the company said it would not comply with NAD recommendations to discontinue claims that the product “kills” lice.

Read More

NAD Recommends National Media Group Discontinue Challenged Claims for Neurocet Supplement, Including All Pain-Relief Claims

NAD has recommended that National Media Group discontinue pain relief claims made for the company’s Neurocet dietary supplement, including the claim “Pain relief 48 time stronger than morphine.”

Read More

NAD Refers Health Claims made for Adderin Supplement to FTC for Review after Advertiser KNH Online Fails to Provide Substantiation

NAD has referred advertising claims made by KNH Online, Inc., for its Adderin Dietary Supplement to the Federal Trade Commission after the company failed to respond to a request for substantiation.

Read More

NAD Recommends Shell Modify, Discontinue Certain Claims for V-Power NiTRO Premium Gasoline Following BP Challenge; Advertiser to Appeal

NAD has recommended that Shell Oil Company modify or discontinue certain challenged claims for the company’s Shell V-Power NiTRO+ Premium Gasoline. The company has said it will appeal NAD’s recommendations to the National Advertising Review Board.

Read More

ThermiGen Says it will Voluntarily Discontinue Certain Claims for ‘ThermiVa’ Device Following Challenge from Viveve

ThermiGen, LLC., said it has voluntarily and permanently discontinued certain advertising claims for the company’s ThermiVa medical device.

Read More